Nectar Lifescience Ltd share price logo

Nectar Lifescience Share Price

NSE: NECLIFE

BSE: 532649

Small Cap

Healthcare Sector

₹10.96

-0.13

(-1.17%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nectar Lifescience Stock Performance

as on March 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹10.94
    ₹11.37
    downward going graph

    0.18%

    Downside

    3.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹10.80
    ₹28.25
    downward going graph

    1.46%

    Downside

    157.76%

    Upside

    downward going graph

Nectar Lifescience share price movements today

Previous Close
₹11.09
Open
₹11.09
Volume
2.96L
Upper Circuit
₹11.64
Lower Circuit
₹10.54
Day's Low - High
₹10.94 - ₹11.37
52 Week Low - High
₹10.80 - ₹28.25

Nectar Lifescience Historical Returns

1 Month Return
-13.43 %
3 Month Return
-50.54 %
1 Year Return
-54.86 %
3 Year Return
-32.97 %
5 Year Return
-44.22 %

Nectar Lifescience Fundamentals

as on March 20, 2026 at 4:01 pm IST

Market Cap

₹212.91 Cr

Return on Equity (ROE)

-11.23

PE Ratio (TTM)

-0.69

Return on capital employed (ROCE)

-5.33

Industry PE ratio

40.5

Beta (LTM)

0.9

P/B Ratio

0.54

Dividend Yield

0

PEG Ratio

0.04

Quarterly Earnings Growth YOY

82.02

EPS (TTM)

-5.07

Sector

Pharmaceuticals

Book Value

42.63

Technical Analysis

Bearish

View Technical Analysis

Nectar Lifescience Stock Valuation

as on March 20, 2026 at 4:01 pm IST

Nectar Lifescience in the last 5 years

  • Overview

  • Trends

Lowest (-284.58x)

December 21, 2023

Today (-0.69x)

March 20, 2026

Industry (40.50x)

March 20, 2026

Highest (403.33x)

August 26, 2020

LowHigh

Today’s Price to Earnings Ratio: -0.69x

Nectar Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nectar Lifescience with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nectar Lifescience Ltd image
Nectar Lifescience Ltd
NA212.91-8.84%0.69-1141,669
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA10.8545.85%0.00-121
Lasa Supergenerics Ltd image
Lasa Supergenerics Ltd
NA35.72-17.76%0.00-15142
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA2,026.882.15%0.571181,811
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
BUY1,202.5833.45%0.5082623
See all

Nectar Lifescience Stock’s Investor Sentiment and Interest

Search interest for Nectar Lifescience Ltd Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Nectar Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
387.89
394.12
397.96
452.16
439.85
358.85
5.73
-
428.91
5.23
-
-
Other Income
17.92
0.47
10.61
0.48
1.47
0.55
6.52
8.08
0.08
0.32
0.03
88.81
Total Income
406.74
394.6
408.57
452.65
442.84
359.85
12.25
8.08
430.77
5.56
0.74
88.81
Expenses
370.72
358.58
371.1
409.98
392.87
319.5
6.32
0.05
585
68.63
176.47
55.28
Operating Profit
17.17
35.54
26.86
42.18
46.98
39.35
-0.59
-0.05
-156.09
-63.4
-176.47
-55.28
Operating Profit Margin %
4.43%
9.02%
6.75%
9.33%
10.68%
10.97%
-10.3%
0%
-36.39%
-1212.24%
0%
0%
Profit Before Interest, Tax and Depreciation
36.01
36.01
37.47
42.67
49.97
40.35
5.93
8.03
-154.23
-63.07
-175.73
33.53
Interest
19.66
17.62
20.52
24.84
24.16
19.98
-
-
17.67
-
-
30.22
Depreciation
14.85
15.33
15.31
15.37
14.7
15.46
0.45
0.07
15.77
0.53
0.11
0.06
Profit Before Tax
1.5
3.06
1.64
2.46
11.11
4.91
5.48
7.96
-187.67
-63.6
-175.84
3.25
Tax Paid
-2.17
1.24
0.63
0.89
10.52
1.95
-0.12
0.12
-57.58
-0.37
0.16
-11.02
Profit After Tax
3.68
1.82
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
-176.01
14.27
Total Net profit including share of profit / Loss from associate company
3.68
1.82
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
-176.01
14.27
EPS
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
Actual EPS
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
Adjusted EPS
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
Diluted EPS
0.16
0.08
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64

Nectar Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,643.7
1,876.26
2,782.86
2,366.38
1,543.3
1,668.83
1,523.67
1,684.09
21.32
Other Income
22.37
5.58
5.96
4.01
2.72
11.29
42.24
13.03
1.62
Total Income
1,666.36
1,882.3
2,788.9
2,370.74
1,547.09
1,680.15
1,566.85
1,698.66
22.96
Expenses
1,419.28
1,640.1
2,518.69
2,146.68
1,459.57
1,510.29
1,470.66
1,532.53
135.59
Operating Profit
224.42
236.16
264.17
219.7
83.73
158.54
53.01
151.56
-114.27
Operating Profit Margin %
13.65%
12.59%
9.49%
9.28%
5.43%
9.5%
3.48%
9%
-535.98%
Profit Before Interest, Tax and Depreciation
247.08
242.19
270.21
224.06
87.52
169.86
96.19
166.13
-112.63
Interest
117.41
115.2
148.14
125.83
112.03
78.81
79.49
87.14
0.01
Depreciation
62.25
64.31
63.26
60.77
60.25
56.97
59.12
60.72
2.08
Profit Before Tax
67.42
62.68
58.81
37.46
-84.76
34.08
-42.42
18.27
-114.72
Tax Paid
12.08
10.41
11.22
5.68
-11.5
9.03
-18.24
13.27
-1.03
Profit After Tax
55.34
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
Total Net profit including share of profit / Loss from associate company
55.34
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
Actual EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
Adjusted EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
Diluted EPS
2.47
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02

Nectar Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
168.82
198.75
65.17
239.24
284.96
21.38
95.01
133.65
224.69
169.44
Cash Flow from Investing Activities
-76.88
-18.11
-29.43
-26.13
-33.13
-28.62
16.64
51.71
-17.03
-41.93
Cash Flow from Financing Activities
-88.68
-204.12
-39.6
-201.09
-251.87
11.48
-119.38
-185.59
-205.44
-128.09
Net Cash Flow
3.26
-23.47
-3.87
12.02
-0.03
4.25
-7.73
-0.23
2.23
-0.58

Nectar Lifescience Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jan 2026
Promoters
55.8%
55.8%
55.8%
55.8%
55.8%
55.8%
44.53%
44.53%
44.53%
44.91%
44.91%
51.84%
DII
0%
0%
0%
0%
0%
0%
0%
0.16%
0.19%
0.09%
5.82%
3.54%
FII
14.59%
14.59%
14.59%
16.97%
16.61%
3.24%
0.73%
1.65%
0.81%
0.62%
0.52%
0.58%
Government
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
28.18%
28.16%
28.06%
27.21%
27.57%
40.94%
54.72%
53.65%
54.44%
54.37%
48.73%
44.01%
Total Outstanding Shares
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
19,42,60,970
Total Shareholders
61,582
60,283
60,761
59,946
58,230
66,741
69,482
69,241
71,977
76,470
78,124
76,648

Mutual Funds that own Nectar Lifescience Stock

Check out the Mutual Funds with significant holdings in Nectar Lifescience.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.01%
1520

Nectar Lifescience Corporate Actions

View detailed summary of the earnings and dividend history of Nectar Lifescience.

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit jumped 82.02% since last year same period to ₹14.27Cr in the Q3 2025-2026. On a quarterly growth basis, Nectar Lifescience Ltd has generated 108.11% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 per share on 29 Jul 2020 - translating a dividend yield of 0.46%.

    Read More about Dividends

Indices Featuring Nectar Lifescience Stock

Check stock indices that include Nectar Lifescience.

BSE Healthcare

₹42,306.40

1.45 (▲605.09%)

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 44.91% to 51.84% in Jan 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 0.74 Cr → 88.81 Cr (in ₹), with an average increase of 99.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.52% to 0.58% in Jan 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -176.01 Cr → 14.27 Cr (in ₹), with an average increase of 1333.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 30.5% return, outperforming this stock by 85.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 181.2% return, outperforming this stock by 214.2%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 48.73% to 44.01% in Jan 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NECLIFE stock has moved down by -50.5%

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Revenue: ₹0.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹14.27Cr as on December 2025 (Q3 FY26)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEOSanjiv Goyal
E-voting on sharesClick here to vote

FAQs

What is Nectar Lifescience share price today?

Nectar Lifescience share price today stands at ₹10.96 as on at the close of the market. Nectar Lifescience share today touched a day high of ₹11.37 and a low of ₹10.94.

What is the 52 week high and 52 week low range for Nectar Lifescience share?

Nectar Lifescience touched a 52 week high of ₹28.25 and a 52 week low of ₹10.8. Nectar Lifescience share price today i.e. is closed at ₹10.96, which is -61.20% down from its 52 week high and 1.48% up from its 52 week low.

What is Nectar Lifescience's market capitalisation today?

Nectar Lifescience market capitalisation is ₹212.91 Cr as on .

How to buy Nectar Lifescience shares?

To buy Nectar Lifescience shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NECLIFE or Nectar Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nectar Lifescience shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nectar Lifescience trading volume today?

Nectar Lifescience trading volume is 2.96L as on . This means that 2.96L shares of Nectar Lifescience were bought and sold on the stock market during today's trading session.